0001209191-24-000783.txt : 20240104
0001209191-24-000783.hdr.sgml : 20240104
20240104162650
ACCESSION NUMBER: 0001209191-24-000783
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240102
FILED AS OF DATE: 20240104
DATE AS OF CHANGE: 20240104
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Lukatch Heath
CENTRAL INDEX KEY: 0001596385
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39323
FILM NUMBER: 24512297
MAIL ADDRESS:
STREET 1: 326 BOLLAY DRIVE
CITY: GOLETA
STATE: CA
ZIP: 93117
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Vaxcyte, Inc.
CENTRAL INDEX KEY: 0001649094
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 464233385
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 825 INDUSTRIAL ROAD, STE. 300
CITY: SAN CARLOS
STATE: CA
ZIP: 94070
BUSINESS PHONE: 650-837-0111
MAIL ADDRESS:
STREET 1: 825 INDUSTRIAL ROAD, STE. 300
CITY: SAN CARLOS
STATE: CA
ZIP: 94070
FORMER COMPANY:
FORMER CONFORMED NAME: SutroVax, Inc.
DATE OF NAME CHANGE: 20150724
4
1
doc4.xml
FORM 4 SUBMISSION
X0508
4
2024-01-02
0
0001649094
Vaxcyte, Inc.
PCVX
0001596385
Lukatch Heath
C/O VAXCYTE, INC.
825 INDUSTRIAL ROAD, STE. 300
SAN CARLOS
CA
94070
1
0
0
0
1
Common Stock
2024-01-02
4
M
0
13000
16.00
A
18625
D
Common Stock
2024-01-02
4
S
0
1101
62.853
D
17524
D
Common Stock
2024-01-02
4
S
0
7444
63.552
D
10080
D
Common Stock
2024-01-02
4
S
0
4164
64.28
D
5916
D
Common Stock
2024-01-02
4
S
0
291
65.192
D
5625
D
Stock Option (right to buy)
16.00
2024-01-02
4
M
0
13000
0.00
D
2030-06-10
Common Stock
13000
15000
D
The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 11, 2023.
The price reported is a weighted-average price. The shares were sold at prices ranging from $62.01 to $62.96. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
The price reported is a weighted-average price. The shares were sold at prices ranging from $63.01 to $64.00. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
The price reported is a weighted-average price. The shares were sold at prices ranging from $64.015 to $64.99. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
The price reported is a weighted-average price. The shares were sold at prices ranging from $65.12 to $65.28. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
Fully vested and exercisable.
Heath Lukatch, by /s/ Ron A. Metzger, Attorney-in-Fact
2024-01-04